Syschem (India) Ltd is Rated Hold

1 hour ago
share
Share Via
Syschem (India) Ltd is rated 'Hold' by MarketsMojo, with this rating last updated on 14 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 June 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, valuation, financial trends, and technical outlook.
Syschem (India) Ltd is Rated Hold

Current Rating and Its Significance

MarketsMOJO’s 'Hold' rating for Syschem (India) Ltd indicates a cautious stance for investors. This rating suggests that while the stock has certain strengths, it may not offer significant upside potential relative to its risks at present. Investors are advised to maintain their existing positions rather than aggressively buying or selling the stock. The rating was revised on 14 May 2026, reflecting a reassessment of the company’s overall profile, but the following analysis is grounded in the latest data available as of 23 June 2026.

Quality Assessment

As of 23 June 2026, Syschem’s quality grade is assessed as average. The company’s return on equity (ROE) stands at 8.92%, which is modest and indicates limited profitability generated from shareholders’ funds. This level of ROE suggests that while the company is generating profits, it is not maximising shareholder capital efficiently compared to higher-quality peers in the Pharmaceuticals & Biotechnology sector. However, the company’s ability to consistently declare positive results over the last six consecutive quarters demonstrates operational stability and resilience in a competitive industry.

Valuation Perspective

Currently, Syschem (India) Ltd is considered attractively valued, with a price-to-book (P/B) ratio of 2.3. This valuation is relatively modest when compared to its sector peers, indicating that the stock is trading at a discount to its historical averages. Despite the stock’s one-year return of -5.36%, the company’s profits have surged by an impressive 902% over the same period, highlighting a disconnect between market price and underlying earnings growth. The PEG ratio is effectively zero, signalling that the stock’s price does not fully reflect its earnings growth potential, which may appeal to value-oriented investors seeking opportunities in microcap pharmaceuticals.

Financial Trend and Performance

The latest data shows an outstanding financial trend for Syschem. Net sales have grown at an annualised rate of 52.98%, reflecting robust top-line expansion. Operating profit has surged by 388.02%, with the company reporting its highest quarterly PBDIT of ₹9.37 crores and an operating profit margin of 4.27% in the most recent quarter. Profit before tax (PBT) excluding other income reached ₹5.60 crores, underscoring strong operational leverage. Additionally, the company maintains a very low debt-to-EBITDA ratio of 0.04 times, indicating a strong capacity to service debt and a conservative capital structure. These financial trends suggest that Syschem is on a solid growth trajectory, supported by improving profitability and prudent financial management.

Technical Outlook

From a technical standpoint, the stock is mildly bearish. Recent price movements show a 1-month decline of 14.18% and a 6-month decline of 9.20%, reflecting some short-term selling pressure. However, the 3-month return is positive at 1.32%, indicating some recovery attempts. The stock’s day change is flat at 0.00%, and the year-to-date return is -6.29%. These mixed signals suggest that while the stock faces some resistance, it is not in a strong downtrend. Investors should monitor technical indicators closely for signs of sustained momentum or further weakness.

Additional Insights

Promoter confidence in Syschem remains high, with promoters increasing their stake by 4.15% over the previous quarter to hold 60.86% of the company. This increased promoter holding is often viewed as a positive signal, reflecting belief in the company’s future prospects. Despite some challenges in management efficiency, the company’s consistent quarterly performance and strong financial health provide a balanced outlook for investors.

Momentum just kicked in! This Small Cap from the Auto - Trucks sector entered our list with explosive short-term signals. Catch the wave while it's still building!

  • - Fresh momentum detected
  • - Explosive short-term signals
  • - Early wave positioning

Catch the Wave Now →

What This Rating Means for Investors

For investors, the 'Hold' rating on Syschem (India) Ltd suggests a balanced approach. The company exhibits strong financial growth and attractive valuation metrics, but the average quality grade and mildly bearish technical signals temper enthusiasm. Investors currently holding the stock may consider maintaining their positions to benefit from ongoing operational improvements and promoter confidence. Prospective buyers should weigh the company’s growth potential against the risks posed by moderate profitability and recent price volatility.

Sector and Market Context

Operating within the Pharmaceuticals & Biotechnology sector, Syschem faces a competitive environment where innovation, regulatory compliance, and efficient capital utilisation are critical. The company’s microcap status means it may be more susceptible to market fluctuations and liquidity constraints compared to larger peers. Nonetheless, its recent financial performance and promoter stake increase position it well for potential medium-term growth, provided it can sustain operational momentum and improve management efficiency.

Summary

In summary, Syschem (India) Ltd’s current 'Hold' rating by MarketsMOJO reflects a nuanced view of the company’s prospects. The rating, updated on 14 May 2026, is supported by a combination of average quality, attractive valuation, outstanding financial trends, and cautious technical signals as of 23 June 2026. Investors should consider these factors carefully when making portfolio decisions, recognising both the opportunities and challenges inherent in this microcap pharmaceutical stock.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News